ARCHIVES

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

NCI To Fund 29% Of Grants In 1990, With Budget Cuts

February 17, 1989

Cancer Policy: EMFs “Possible” Carcinogen, Panel Says; Plans Public Hearings

August 7, 1998

Cancer Training Programs Fairing Fairley Well

December 1, 1989

FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections

August 18, 1978

Gerstner Resigns From NA, MSK Board After Taking RJR Job

March 24, 1989

Center Directors, NCI Staff Agree- They Have Problems

November 26, 1976